The insider has been selling a consistent 2,000-share block each month since August 2026, suggesting a pre-arranged 10b5-1 plan or routine portfolio diversification. No material change in company outlook is signaled by this filing alone.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 3 $533.65entry
- T+1 · 13d ago +2.81%α +1.16% · $548.64
- T+5 · 7d ago +2.03%α +2.62% · $544.49
- T+9 · todayOpen
- T+20 · in 15d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Kevin J. McNamara, an officer/director of Chemed Corp, filed a Form 144 notice of intent to sell 2,000 shares of common stock, with an estimated aggregate market value of approximately $1.08 million based on a recent price of $542.18. The shares were acquired through stock awards and exercises in 2023 and 2025. This is a routine insider sale notice and represents a small fraction of the insider's total holdings and the company's $7.1B market cap.
Key Facts
- Kevin J. McNamara, an officer/director, filed Form 144 on 2026-11-03.
- Proposed sale of 2,000 shares of Chemed Corp common stock.
- Estimated aggregate market value of the sale is approximately $1.08 million (2,000 shares at ~$542.18 per share).
- Shares were acquired through stock awards and exercises on 05/05/2025 (1,018 shares), 02/14/2025 (679 shares), and 05/02/2023 (303 shares).
- The sale is planned for execution on or after 11/03/2026 on the NYSE.
- The insider has sold shares in three recent transactions (08/21/2026, 09/17/2026, 09/28/2026), each for 2,000 shares at prices around $541-$513.
- The proposed sale represents less than 0.02% of Chemed's $7.1B market cap.
Financial Impact
Proposed sale of 2,000 shares valued at ~$1.08M, less than 0.02% of market cap.
Risk Factors
- Form 144 is an intent to sell; the sale may not occur.
- Insider selling could be misinterpreted as a negative signal, but the pattern appears routine.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001628280-26-069375 |
| Document: 0001628280-26-069375-index.html | 0001628280-26-069375 |
| Document: 0001628280-26-069375.txt | 0001628280-26-069375 |
Track record
19 reports on CHE
2 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +2.86% at T+5 after the Oct 27, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 6, 202610d ago Press Release Neutral 2/10 Entry $528.05 to $548.20 Now $549.45 +4.05% ▲ +3.82% +1.22% vs SPY
- Nov 5, 202611d ago Insider Cluster Bearish 4/10 Entry $533.77 to $550.20 Now $549.45 −2.94% ▼ −3.08% +0.21% vs SPY
- Nov 3, 202613d ago 144 Neutral 2/10 Viewing Entry $533.65 to $544.49 Now $549.45 +2.96% ▲ +2.03% +2.62% vs SPY
- Oct 27, 202620d ago Institutional Cluster Mixed 4/10 Entry $533.36 to $548.64 Now $549.45 +3.02% ▲ +2.86% +3.58% vs SPY
- Oct 27, 202620d ago 8-K Bullish 6/10 No price data
- Oct 27, 202620d ago Press Release Bullish 6/10 Entry $533.36 to $548.64 Now $549.45 +3.02% ▲ +2.86% +3.58% vs SPY
- Oct 23, 202624d ago Institutional Cluster Mixed 3/10 Entry $512.98 to $534.72 Now $549.45 +7.11% ▲ +4.24% +4.80% vs SPY
- Oct 1, 20266w ago Press Release Neutral 1/10 Entry $502.90 to $498.25 Now $549.45 +9.26% ▼ −0.92% −2.23% vs SPY
- Sep 16, 20268w ago Press Release Neutral 4/10 Entry $505.97 to $495.65 Now $549.45 +8.59% ▼ −2.04% −2.64% vs SPY
- Aug 24, 202612w ago Insider Cluster Neutral 3/10 Entry $541.34 to $518.71 Now $549.45 +1.50% ▼ −4.18% −4.65% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers